AVI-4658 (Eteplirsen)
4658-us-202
Phase 2 small_molecule completed
Quick answer
AVI-4658 (Eteplirsen) for Duchenne Muscular Dystrophy (DMD) is a Phase 2 program (small_molecule) at Sarepta Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sarepta Therapeutics
- Indication
- Duchenne Muscular Dystrophy (DMD)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed